Kaul, Arvind
Gordon, Caroline
Crow, Mary K.
Touma, Zahi
Urowitz, Murray B.
van Vollenhoven, Ronald
Ruiz-Irastorza, Guillermo
Hughes, Graham
Article History
First Online: 16 June 2016
Competing interests
: A.K. has received honoraria for speaking as well as research grants from Janssen, Celgene, Pfizer and Wyeth. C.G. has received consulting fees and/or honoraria from Bristol-Myers Squibb (BMS), GlaxoSmithKline (GSK), Lilly, Merck Serono, Parexel and UCB and grant support from UCB. R.v.V. has received research support or grants from AbbVie, Amgen, BMS, GSK, Pfizer, Roche and UCB and consulting fees or honoraria from AbbVie, Biotest, BMS, Celgene, Crescendo, GSK, Janssen, Lilly, Merck, Novartis, Pfizer, Roche, UCB and Vertex. M.K.C. has received consulting fees or research support from AstraZeneca, BMS, GSK, Lilly, MedImmune, Novartis, Novo Nordisk and Pfizer. All other authors declare no competing interests.